Artiva Biotherapeutics Inc (ARTV) - News Archive

Artiva Biotherapeutics, Inc. is poised to make a significant impact in the fight against B-cell non-Hodgkin lymphoma (NHL) through its innovative therapy, AlloNK, combined with the monoclonal antibody rituximab. At the...

Artiva Biotherapeutics Inc presents a compelling narrative as it reports its financial results for the third quarter of 2024. This report encapsulates the company s ongoing commitment to advancing innovative therapies,...

Artiva Biotherapeutics: Revolutionizing the Field of Cell Therapy The highly anticipated initial public offering (IPO) of Artiva Biotherapeutics, a leading biotechnology company focused on developing innovative cellular...